Classification of Movement DisordersFAHN, Stanley.Movement disorders. 2011, Vol 26, Num 6, pp 947-957, issn 0885-3185, 11 p.Article

Tolcapone: COMT inhibition for the treatment of Parkinson's diseaseFAHN, Stanley.Neurology. 1998, Vol 50, Num 5, issn 0028-3878, 62 p., SUP5Serial Issue

Parkinson's Disease Foundation symposium, New York City, 1987FAHN, Stanley; MAYEUX, Richard.Movement disorders. 1989, Vol 4, pp S1-S144, issn 0885-3185, [ 144 p.], suppl. 1Conference Proceedings

Influence of COMT inhibition on levodopa pharmacology and therapyGOETZ, C. G.Neurology. 1998, Vol 50, Num 5, pp S26-S30, issn 0028-3878, SUP5Article

Pharmacokinetics, pharmacodynamics, and tolerability of tolcapone : a review of early studies in volunteersJORGA, K. M.Neurology. 1998, Vol 50, Num 5, pp S31-S38, issn 0028-3878, SUP5Article

Levodopa therapy : Consequences of the nonphysiologic replacement of dopamineCHASE, T. N.Neurology. 1998, Vol 50, Num 5, pp S17-S25, issn 0028-3878, SUP5Article

Highlights of the North American and European experiencesGOETZ, C. G.Neurology. 1998, Vol 50, Num 5, pp S15-S16, issn 0028-3878, SUP5Article

Overview, history, and classification of myoclonusFAHN, Stanley.Advances in neurology. 2002, Vol 89, pp 13-17, issn 0091-3952, 5 p.Conference Paper

The early history of paroxysmal dyskinesiasFAHN, Stanley.Advances in neurology. 2002, Vol 89, pp 377-385, issn 0091-3952, 9 p.Conference Paper

Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson diseaseARKADIR, David; BERGMAN, Hagai; FAHN, Stanley et al.Neurology. 2014, Vol 82, Num 12, pp 1093-1098, issn 0028-3878, 6 p.Article

Diagnosis and management of pergolide-induced fibrosisAGARWAL, Pinky; FAHN, Stanley; FRUCHT, Steven J et al.Movement disorders. 2004, Vol 19, Num 6, pp 699-704, issn 0885-3185, 6 p.Article

Posthypoxic MyoclonusFRUCHT, Steven; FAHN, Stanley; HALLETT, Mark et al.Movement disorders. 2000, Vol 15, issn 0885-3185, 61 p., SUP1Serial Issue

COMT inhibition : A new treatment strategy for Parkinson's diseaseKURTH, M. C; ADLER, C. H.Neurology. 1998, Vol 50, Num 5, pp S3-S14, issn 0028-3878, SUP5Article

How Do You Treat Motor Complications in Parkinson's Disease : Medicine, Surgery, or Both?FAHN, Stanley.Annals of neurology. 2008, Vol 64, Num 6, issn 0364-5134, S56-S64, SUPArticle

Physiology of human posthypoxic myoclonusHALLETT, M.Movement disorders. 2000, Vol 15, pp 8-13, issn 0885-3185, SUP1Article

Severe cervical dystonia in pathologically proven Parkinson's disease and dementiaCOHEN, Oren; FAHN, Stanley; FRUCHT, Steven J et al.Movement disorders. 2003, Vol 18, Num 11, pp 1381-1382, issn 0885-3185, 2 p.Article

The unified myoclonus rating scaleFRUCHT, Steven J; LEURGANS, Sue E; HALLETT, Mark et al.Advances in neurology. 2002, Vol 89, pp 361-376, issn 0091-3952, 16 p.Conference Paper

Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutationNIRENBERG, Melissa J; LIBIEN, Jenny; VONSATTEL, Jean-Paul et al.Movement disorders. 2007, Vol 22, Num 2, pp 251-254, issn 0885-3185, 4 p.Article

Managing motor fluctuations, dyskinesias, and other adverse effects in Parkinson's diseaseTANNER, C. M; MELAMED, E; LEES, A. J et al.Neurology. 1994, Vol 44, Num 3, pp S12-S16, issn 0028-3878, SUP1Article

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonusFRUCHT, Steven J; LOUIS, Elan D; CHUANG, Cathy et al.Neurology. 2001, Vol 57, Num 6, pp 1112-1114, issn 0028-3878Article

Dystonia 3FAHN, Stanley; MARSDEN, Charles David; DELONG, Mahlon R et al.Advances in neurology. 1998, Vol 78, issn 0091-3952, 392 p.Conference Proceedings

The History of Dopamine and Levodopa in the Treatment of Parkinson's DiseaseFAHN, Stanley.Movement disorders. 2008, Vol 23, issn 0885-3185, S497-S508, SUP3Article

Myoclonus and Paraxysmal DyskinesiasFAHN, Stanley; FRUCHT, Steven J; HALLETT, Mark et al.Advances in neurology. 2002, Vol 89, issn 0091-3952, 517 p.Conference Proceedings

Movement disorders fellowship training program at columbia university medical center in 2001-2002PORTERA-CAILLIAU, Carlos; VICTOR, Daryl; FRUCHT, Steven et al.Movement disorders. 2006, Vol 21, Num 4, pp 479-485, issn 0885-3185, 7 p.Article

Speech dysfluency exacerbated by levodopa in Parkinson's diseaseLOUIS, Elan D; WINFIELD, Linda; FAHN, Stanley et al.Movement disorders. 2001, Vol 16, Num 3, pp 562-565, issn 0885-3185Article